賓仕國際(01705.HK)接獲立興發出的一份傳訊令狀
格隆匯2月2日丨賓仕國際(01705.HK)公佈,於2021年2月2日,公司間接全資附屬公司智耀企業有限公司接獲代表LHM Medical Technology (Hong Kong) Limited立興醫療科技(香港)有限公司(立興,作為原吿)的律師針對智耀(作為被吿),在香港高等法院原訟法庭就編號高院民事訴訟2021年第191號的訴訟發出的一份傳訊令狀。
立興指稱智耀違反智耀與立興於2020年8月13日就生產及供應口罩訂立的私人標籤協議,並向智耀申索975萬港元加損害賠償、利息及費用。
董事會相信,發出高院民事訴訟第191號令狀,與智耀的律師於2021年1月29日在香港高等法院原訟法庭就編號高院民事訴訟2021年第166號的訴訟,針對立興發出的傳訊令狀有關。在高院民事訴訟第166號令狀中,智耀(作為原吿)表示,立興根據該協議交付的貨物未能符合該協議中協定的質量及╱或標準,並向立興提出申索,內容計有:宣佈因立興悔約性違約,令該協議被合法終止;宣佈該協議因失實陳述而被合法撤銷;及損害賠償、利息及費用。
監於上述訴訟的法律程序尚處於初期階段,董事會目前仍在考慮對公司的潛在影響。公司將密切關注事態發展,並繼續就高院民事訴訟第166號令狀及高院民事訴訟第191號令狀尋求法律意見。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.